LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced it ...
A long-lived and sequence-specific ligand–DNA complex would make possible the modulation of biological processes for extended periods. For this purpose, we are investigating a polyintercalation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results